Navigation Links
Neogen Acquires Kane Enterprises

LANSING, Mich., Aug. 27 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) has acquired Kane Enterprises, Inc., a leading manufacturer and marketer of animal health products.

Based in South Dakota, Kane Enterprises markets its products through a network of more than 200 distributors in the United States and Canada. Known for innovative products of exceptional quality, including its well-regarded AG-TEK(R) veterinary product line, Kane Enterprises recorded revenues of approximately $6 million in its most recently completed fiscal year (Sept. 2006). Terms of the acquisition included $5.8 million in cash and a contingency should sales of the acquired products exceed a set level.

Kane's operations will be relocated to and integrated with Neogen's Lexington, Ky., facilities.

"We are pleased to add these products of such excellent reputation to Neogen's offerings," said Lon Bohannon, Neogen's president. "The AG-TEK products are complementary and a nice fit with our vet instruments line that has been growing consistently in the 10-15% range for several years. The Kane purchase also provides Neogen with important synergistic sales opportunities within the dairy industry -- a historically strong market segment for Kane."

"We are very proud of the reputation Kane Enterprises has built in our 31 years of operation," said Kevin Kane, Kane Enterprises' president, who will join Neogen with the acquisition. "We are pleased to join forces with Neogen, and add our AG-TEK products to their excellent offering of superior animal safety solutions."

Established in 1975, Kane Enterprises has grown into an international company with over 100 different products imported from eight countries and sold in over 12 countries. A few of its leading products include its AG-TEK veterinary obstetrical artificial insemination gloves, bovine hoofcare, and surgical supplies. For more information on Kane Enterprises, visit its Web site at

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward- looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.

SOURCE Neogen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Fiserv acquires crime management software firm
2. GenTel acquires GlaxoSmithKline chip platform
3. Tushaus Computer acquires managed service business
4. RedPrairie acquires Denver software company
5. Eagle Technology acquires some synergy
6. Brady Corp. acquires Korean counterpart
7. Canadian firm acquires Silicon Logic
8. Imago acquires synergistic British firm
9. Fiserv acquires insurance, training product lines
10. Amazon acquires Madison-based Shopbop
11. Metavante acquires health-care payments firm
Post Your Comments:
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... , November 25, 2015 Studies ... and human plaque and pave the way for more effective ... in cats     --> ... commonly diagnosed health problems in cats, yet relatively little was ... Two collaborative studies have been conducted by researchers from the ...
Breaking Biology Technology:
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):